Show simple item record

dc.contributor.authorWaidhofer, H.K.G.
dc.contributor.authorVirú-Flores, H.
dc.contributor.authorRoque-Quezada, J.C.
dc.contributor.authorAlburqueque-Melgarejo, J.
dc.contributor.authorDíaz, C.V.S.
dc.contributor.authorGironzini, Á.B.A.
dc.date.accessioned2025-10-31T18:40:10Z
dc.date.available2025-10-31T18:40:10Z
dc.date.issued2023
dc.identifier.urihttps://revistamedicaderosario.org/index.php/rm/article/view/200
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5793
dc.description.abstractObjective: To determine a cut-off point and the operational characteristics of the C-reactive protein in the severity of COVID-19 infection in adult patients treated at the Corazón de Lurín Medical Center during the years 2020 to 2021. Materials and methods: Observational, descriptive, retrospective, cross-sectional, diagnostic test type design, we worked with a sample size of 502 patients with SARS COV-2. A binary logistic regression model was used to obtain the operational characteristics of the C-reactive protein for the diagnosis of Severe SARS COV-2, as well as a ROC curve to obtain the area under the curve (AUC) with their respective intervals of confidence and optimal cut-off point. Likewise, the Fagan normogram was used to represent the pre-test and post-test probability. Results: An AUC of 79.5%, an overall precision of 77.49%, a sensitivity of 80.66%, a specificity of 75.10%, a positive predictive value of 65.18%, and a negative predictive value of 87.41% were obtained. Values of 36.06%, 65% and 13% were obtained for the pre-test probability, negative post-test probability and positive post-test, respectively. In addition to this, the maximum positive (3.32) and negative (0.26) likelihood ratios were calculated. Conclusions: It can be stated that C-reactive protein on admission is an adequate early marker for the prognosis of severity due to COVID-19 disease.en_US
dc.formatapplication/pdf
dc.language.isospa
dc.publisherCirculo Médico de Rosario
dc.relation.ispartofurn:issn:1851-2135
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectCOVID-19, Its Impact, and Vaccinationen_US
dc.subjectClinical Insights into COVID-19 Patient Outcomesen_US
dc.titlePROTEÍNA C REACTIVA DE INGRESO COMO PREDICTOR PRECOZ EN LA SEVERIDAD POR COVID-19 EN UN CENTRO DE SALUD DE REFERENCIA DEL PERÚes_PE
dc.title.alternativeC-REACTIVE PROTEIN ON ADMISSION AS AN EARLY PREDICTOR OF COVID-19 SEVERITY IN A REFERENCE HEALTH CENTER IN PERUen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.27
dc.type.otherResearch article
dc.identifier.journalRevista Medica de Rosario
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2